Fractional flow reserve in patients with coronary artery disease undergoing TAVI: a prospective analysis

Anja Stundl1, Jasmin Shamekhi1, Svenja Bernhardt1

  • 1Heart Center Bonn, Department of Medicine II, University Hospital Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.

Insights

Coronary artery disease (CAD) is common in aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI). Fractional flow reserve (FFR) measurements remain stable post-TAVI, suggesting a potential for conservative management of non-left main coronary stenoses.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Aortic stenosis (AS) frequently coexists with coronary artery disease (CAD).
  • Transcatheter aortic valve implantation (TAVI) is a primary treatment for severe AS.
  • The hemodynamic significance of CAD in AS patients undergoing TAVI requires further investigation.

Purpose of the Study:

  • To determine the prevalence of CAD in AS patients.
  • To assess changes in the hemodynamic significance of coronary lesions after TAVI using fractional flow reserve (FFR).
  • To explore the impact of FFR-positive CAD on patient outcomes and develop a management algorithm.

Main Methods:

  • Diagnostic coronary angiography was performed in 246 AS patients before TAVI.
  • FFR was measured for coronary lesions with ≥50% diameter stenosis.
  • Follow-up angiography and FFR were conducted 6-8 weeks post-TAVI in patients with positive FFR (≤0.80).

Main Results:

  • Concomitant CAD was present in 53.3% of patients.
  • FFR measurements before and after TAVI showed no significant hemodynamic changes (0.77 ± 0.04 vs. 0.76 ± 0.08; p=0.11).
  • 35.9% of CAD patients underwent percutaneous coronary intervention (PCI) before TAVI for significant left main or severe stenoses.

Conclusions:

  • Concomitant CAD is highly prevalent in AS patients undergoing TAVI.
  • FFR is a valid tool for assessing coronary lesions in this population, as values remain stable post-TAVI.
  • Conservative management of non-left main coronary stenoses <90% diameter stenosis after TAVI may be considered due to low adverse event rates.
Abstract